High expression of vanilloid receptor-1 is associated with better prognosis of patients with hepatocellular carcinoma.
暂无分享,去创建一个
Tao Zhang | X. Miao | Wen-tao Fan | Qunwei Wang | Xundi Xu | C. Xie | Guoxing Liu | Qinglong Li | Guoli Liu | Songwen Hua | De-wu Zhong | Yaohui Yang | Shengfu Huang | F. Sun
[1] V. Mazzaferro,et al. Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma , 2007, Hepatology.
[2] Stephen P. H. Alexander,et al. Vanilloid receptor agonists and antagonists are mitochondrial inhibitors: how vanilloids cause non-vanilloid receptor mediated cell death. , 2007, Biochemical and biophysical research communications.
[3] D. Geraghty,et al. Expression of transient receptor potential vanilloid 1 (TRPV1) and 2 (TRPV2) in human peripheral blood. , 2007, Molecular immunology.
[4] X. Miao,et al. Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma. , 2006, Cancer genetics and cytogenetics.
[5] C. Ledent,et al. CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis , 2006, Nature Medicine.
[6] Sören Lehmann,et al. Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells. , 2006, Cancer research.
[7] Y. Murata,et al. Apoptosis induction by dohevanil, a DHA substitutive analog of capsaicin, in MCF-7 cells. , 2006, Life sciences.
[8] Immunohistochemical distribution of vanilloid receptor, calcitonin-gene related peptide and substance P in gastrointestinal mucosa of patients with different gastrointestinal disorders , 2006, InflammoPharmacology.
[9] M. Spinelli,et al. Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder. , 2005, European urology.
[10] H. Friess,et al. Vanilloids in pancreatic cancer: potential for chemotherapy and pain management , 2005, Gut.
[11] M. Makuuchi,et al. Prognostic Impact of Anatomic Resection for Hepatocellular Carcinoma , 2005, Annals of surgery.
[12] A. M. Sánchez,et al. Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue. , 2005, European journal of pharmacology.
[13] T. Pawlik,et al. Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. , 2005, Archives of surgery.
[14] L. Csiba,et al. Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain. , 2005, Brain research. Molecular brain research.
[15] N. Carruthers,et al. Selective Blockade of the Capsaicin Receptor TRPV1 Attenuates Bone Cancer Pain , 2005, The Journal of Neuroscience.
[16] W. Jiménez,et al. Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors , 2005, Gut.
[17] Liying Li,et al. Antifibrogenic role of the cannabinoid receptor CB2 in the liver. , 2005, Gastroenterology.
[18] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[19] Donna H. Wang. The vanilloid receptor and hypertension , 2005, Acta Pharmacologica Sinica.
[20] S. Kechagias,et al. Expression of vanilloid receptor-1 in epithelial cells of human antral gastric mucosa , 2005, Scandinavian journal of gastroenterology.
[21] Laura R. Sadofsky,et al. EXPRESSION AND CHARACTERIZATION OF THE INTRACELLULAR VANILLOID RECEPTOR (TRPV1) IN BRONCHI FROM PATIENTS WITH CHRONIC COUGH , 2005, Experimental lung research.
[22] Jung-Ae Kim,et al. A phospholipase c-dependent intracellular ca2+ release pathway mediates the capsaicin-induced apoptosis in HepG2 human hepatoma cells , 2005, Archives of pharmacal research.
[23] R. Ramer,et al. Up-Regulation of Cyclooxygenase-2 Expression Is Involved in R(+)-Methanandamide-Induced Apoptotic Death of Human Neuroglioma Cells , 2004, Molecular Pharmacology.
[24] I. Han,et al. Capsaicin, a spicy component of hot pepper, induces apoptosis by activation of the peroxisome proliferator-activated receptor gamma in HT-29 human colon cancer cells. , 2004, Journal of medicinal food.
[25] Ji-Seon Lee,et al. Involvement of NADPH Oxidase-mediated Generation of Reactive Oxygen Species in the Apototic Cell Death by Capsaicin in HepG2 Human Hepatoma Cells , 2004, Free radical research.
[26] Keisuke Ito,et al. Induction of Apoptosis in Leukemic Cells by Homovanillic Acid Derivative, Capsaicin, through Oxidative Stress , 2004, Cancer Research.
[27] M. Monden,et al. Akt2 expression correlates with prognosis of human hepatocellular carcinoma. , 2004, Oncology reports.
[28] Jiefu Zheng,et al. Vanilloid receptors in hearing: altered cochlear sensitivity by vanilloids and expression of TRPV1 in the organ of corti. , 2003, Journal of neurophysiology.
[29] P. Anand,et al. Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency , 2003, The Lancet.
[30] H. El‐Serag. Hepatocellular carcinoma and hepatitis C in the United States , 2002, Hepatology.
[31] M. Uchiba,et al. Ischemia/reperfusion-induced increase in the hepatic level of prostacyclin is mainly mediated by activation of capsaicin-sensitive sensory neurons in rats. , 2002, The Journal of laboratory and clinical medicine.
[32] H M Rosenberg,et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. , 2001, Journal of the National Cancer Institute.
[33] P. Anand,et al. Vanilloid receptor 1 immunoreactivity in inflamed human bowel , 2001, The Lancet.
[34] A. Moon,et al. Capsaicin-induced apoptosis in SK-Hep-1 hepatocarcinoma cells involves Bcl-2 downregulation and caspase-3 activation. , 2001, Cancer letters.
[35] H. El‐Serag,et al. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States , 2001, Hepatology.
[36] A I Basbaum,et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. , 2000, Science.
[37] P. Blumberg,et al. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[38] H. Eguchi,et al. Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[39] F. X. Bosch,et al. Epidemiology of Primary Liver Cancer , 1999, Seminars in liver disease.
[40] A. Basbaum,et al. The Cloned Capsaicin Receptor Integrates Multiple Pain-Producing Stimuli , 1998, Neuron.
[41] M. Kojiro,et al. Expression of vascular endothelial growth factor in human hepatocellular carcinoma , 1998, Hepatology.
[42] D. Julius,et al. The capsaicin receptor: a heat-activated ion channel in the pain pathway , 1997, Nature.
[43] A. Bisceglie,et al. Hepatitis C and Hepatocellular Carcinoma , 1995, Seminars in liver disease.